The expression of MxA in chronic hepatitis C played a role among the mechanisms underlying responsiveness to therapy of pegylated IFN in combination with ribavirin (Giannelli et al., 2004). This evidence concerns the gene IFNA1 and chronic hepatitis C virus infection.